NCT07382011 is a NA clinical trial of LM-Activator™ in Myofunctional Therapy, sponsored by Marmara University.

Who is sponsoring NCT07382011?

NCT07382011 is sponsored by Marmara University.

What drugs are being tested in NCT07382011?

Interventions in NCT07382011: LM-Activator™, Twin Block Appliance.

What condition does NCT07382011 study?

NCT07382011 studies Myofunctional Therapy, Orthodontic Appliance, Malocclusion Class II.

Is NCT07382011 still recruiting?

NCT07382011 is currently completed. Last updated 2 February 2026.

Last reviewed 2026-02-02 · How we verify

NCT07382011

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Craniofacial and Postural Changes Induced by LM-Activator Therapy in Growing Children

Completed NA Last updated 2 February 2026

What this trial tests

NA trial testing LM-Activator™ in Myofunctional Therapy in 26 participants. Completed in 30 September 2025.

Timeline

23 December 2023

Primary endpoint
30 September 2025

30 September 2025

Quick facts

Lead sponsor	Marmara University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	26
Start date	23 December 2023
Primary completion	30 September 2025
Estimated completion	30 September 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

LM-Activator™
Twin Block Appliance

Conditions studied

Myofunctional Therapy — all drugs for Myofunctional Therapy →
Orthodontic Appliance — all drugs for Orthodontic Appliance →
Malocclusion Class II — all drugs for Malocclusion Class II →

Sponsor

Marmara University

Who can join

Adults 8 to 13, any sex, with Myofunctional Therapy or Orthodontic Appliance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective study will compare the effects of LM-Activator™ and Twin Block appliances in 26 children (aged 8-13 years) with Class II malocclusion. Skeletal, dentoalveolar, and cervical posture parameters will be assessed using lateral cephalometric radiographs and digital dental models.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Marmara University trials

Trials by the same sponsor.

NCT07533734 — The Effects of an Augmented Reality-Based Mirror Therapy System in Patients With Stroke · NA · not yet recruiting
NCT07474181 — Simulation-Based Training for Urinary Catheterization Skills in Nursing Students · NA · not yet recruiting
NCT07486349 — Shoulder Pericapsular Block Versus Interscalene Block in Arthroscopic Shoulder Surgery · NA · not yet recruiting
NCT07468110 — Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patients With Chronic Stroke · recruiting
NCT07468097 — The Impact of Metabolic Status on Pain and Central Sensitization in Women With Lipedema: A Cross-Sectional Observational · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07382011 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marmara University
Last refreshed: 2 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07382011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing